Document is current
Any future updates will be listed below
-
Authors
Börner, Katy https://orcid.org/0000-0002-3321-6137
Blood, Philip D.
Silverstein, Jonathan C. https://orcid.org/0000-0002-9252-6039
Ruffalo, Matthew https://orcid.org/0000-0003-2222-6169
Satija, Rahul https://orcid.org/0000-0001-9448-8833
Teichmann, Sarah A. https://orcid.org/0000-0002-6294-6366
Pryhuber, Gloria J. https://orcid.org/0000-0002-9185-3994
Misra, Ravi S.
Purkerson, Jeffrey M.
Fan, Jean https://orcid.org/0000-0002-0212-5451
Hickey, John W.
Molla, Gesmira
Xu, Chuan https://orcid.org/0000-0002-6265-999X
Zhang, Yun https://orcid.org/0000-0003-2707-5881
Weber, Griffin M.
Jain, Yashvardhan https://orcid.org/0000-0002-6300-5568
Qaurooni, Danial https://orcid.org/0000-0001-6190-073X
Kong, Yongxin
,
Abramson, Jakub
Anderson, David
Ardlie, Kristin
Arends, Mark J.
Aronow, Bruce J.
Bajema, Rachel
Baldock, Richard A.
Barnowski, Ross
Barwinska, Daria
Bernard, Amy
Betancur, David
Bidanta, Supriya
Björklund, Frida
Bolin, Axel
Boppana, Avinash
Boulter, Luke
Browne, Kristen
Brusko, Maigan A.
Burger, Albert
Campbell-Thompson, Martha
Cao-Berg, Ivan
Caron, Anita R.
Carroll, Megan
Chadwick, Chrystal
Chen, Haoran
Chen, Lu
de Bono, Bernard
Deutsch, Gail
Ding, Song-Lin
Donahue, Sean
El-Achkar, Tarek M.
Eskaros, Adel
Falo, Louis Jr.
Farrow, Melissa
Ferkowicz, Michael J.
Fisher, Stephen A.
Gee, James C.
Germain, Ronald N.
Ginda, Michael
Ginty, Fiona
Gitomer, Sarah A.
Goldstone, Melanie B.
Gustilo, Katherine S.
Hagood, James S.
Halushka, Marc K.
Haniffa, Muzlifah A.
Hanna, Peter
Hardi, Josef
He, Yongqun Oliver
Honick, Brendan John
Houghton, Derek
Itkin, Maxim
Jain, Sanjay
Jardine, Laura
Jiang, Z. Gordon
Ju, Yingnan
Karunamurthy, Arivarasan
Kelleher, Neil L.
Kendall, Timothy J.
Kruse, Angela R. S.
Laronda, Monica M.
Laurent, Louise C.
Laurenti, Elisa
Lee, Sujin
Lein, Ed
Li, Chenran
Li, Zhuoyan
Lin, Shin
Lin, Yiing
Lindsay, Scott A.
Longacre, Teri A.
Lundberg, Emma
Maier, Libby
Malhotra, Rajeev
Martinez Casals, Anna
Masci, Anna Maria
Mathews, Clayton E.
McDonough, Elizabeth
McLaughlin, James A.
Menon, Rajasree
Menon, Vilas
Miller, Jeremy A.
Morgan, Richard
Müller, Werner
Murphy, Robert F.
Musen, Mark A.
Nakshatri, Harikrishna
Nawijn, Martijn C.
Neumann, Elizabeth K.
Nigra, Debra J.
O’Neill, Kathleen
Parast, Mana M.
Patel, Ushma
Pei, Liming
Phatnani, Hemali
Phillips, Gesina A.
Pouch, Alison M.
Powers, Alvin C.
Puerto, Juan F.
Puig-Barbe, Aleix
Quardokus, Ellen M.
Radtke, Andrea J.
Rajbhandari, Presha
Record, Elizabeth G.
Roberts, Drucilla J.
Ropelewski, Alexander J.
Rowe, David
Ruschman, Nancy L.
Saunders, Diane C.
Scheuermann, Richard H.
Schey, Kevin L.
Schilling, Birgit
Schlehlein, Heidi
Schwenk, Melissa
Scibek, Robin
Seifert, Robert P.
Shirey, Bill
Shivkumar, Kalyanam
Siletti, Kimberly
Simmons, J. Alan
Singhal, Dhruv
Snyder, Michael
Spraggins, Jeffrey M.
Stanley, Valentina
Strand, Douglas W.
Sunshine, Joel C.
Surrette, Christine
Suzuki, Ayako
Tata, Purushothama Rao
Taylor, Deanne M.
Theriault, Todd
Theriault, Tracey
Thomas, Jerin Easo
Tsui, Elizabeth L.
Uranic, Jackie
Valerius, M. Todd
Van Valen, David
Vezina, Chad M.
Vlachos, Ioannis S.
Wang, Fusheng
Wang, Xuefei ‘Julie’
Wasserfall, Clive H.
Welling, Joel S.
Werlein, Christopher
Winfree, Seth
Wright, Devin M.
Yao, Li
Yuan, Zhou
Zhang, Ted
Bueckle, Andreas https://orcid.org/0000-0002-8977-498X
Herr, Bruce W. II https://orcid.org/0000-0002-6703-7647
- License Information
-
More Information
Article History
Received: 27 March 2024
Accepted: 11 November 2024
First Online: 13 March 2025
Competing interests
: The primary authors declare the following competing interests: R. Satija receives compensation from 10x Genomics, Parse Biosciences and Neptune Bio. R.S. is a co-founder and equity holder of Neptune Bio. S. Teichmann is a remunerated member of the Scientific Advisory Boards of QIAGEN, Foresite Labs and Element Biosciences, a co-founder and equity holder of TransitionBio and EnsoCell Therapeutics and a part-time employee of GlaxoSmithKline since January 2024. The HRA Team authors declare the following competing interests: B. Aronow declares Nexstone Immunology, Uniquity and Advisors. C. Werlein declares speaker fees from Boehringer Ingelheim. M. Snyder declares Personalis, SensOmics, Qbio, January AI, Fodsel, Filtricine, Protos, RTHM, Iollo, Marble Therapeutics, Crosshair Therapeutics, NextThought and Mirvie, Jupiter, Neuvivo, Swaza, Mitrix, Yuvan, TranscribeGlass and Applied Cognition. N. Kelleher declares Thermo Fisher Scientific, Proteinaceous, Integrated Protein Technologies and ImmPro. W. Müller declares Miltenyi Biotec. E. Lundberg is an advisor for the Chan-Zuckerberg Initiative Foundation, Element Biosciences, Cartography Biosciences, Pfizer and Pixelgen Technologies. T. Kendall serves as a consultant or advisory board member for Resolution Therapeutics, Clinnovate Health, HistoIndex, Fibrofind, Kynos Therapeutics, Perspectum, Concept Life Sciences and Jazz Pharmaceuticals; and has received speakers' fees from Servier Laboratories, Jazz Pharmaceuticals, Astrazeneca, HistoIndex and Incyte Corporation. A. Ropelewski is an equity holder in Illumina, Nanostring, 10x Genomics and Akoya. L. Falo is a cofounder and equity holder in SkinJect. The remaining authors declare no competing interests.
